The Patent Cooperation Treaty (PCT): How It Works

The Patent Cooperation Treaty (PCT) is an international framework that allows inventors and companies to file a single patent application that preserves the right to seek protection in over 150 contracting states. Administered by the World Intellectual Property Organization (WIPO), the PCT does not issue a single "world patent" — instead, it streamlines the early stages of filing and examination before national or regional patent offices take over final grant decisions. Understanding how the PCT functions is essential context for any applicant navigating international patent protection as part of a broader filing strategy.

Definition and scope

The PCT was established in 1970 and entered into force in 1978 under WIPO administration (WIPO PCT Overview). As of 2023, 157 contracting states are party to the treaty, making it the dominant mechanism for multi-jurisdictional patent filing globally. The legal basis in the United States is found in Chapter 35 of Title 35 of the U.S. Code (35 U.S.C. §§ 351–376), which implements the PCT domestically and establishes the USPTO's role as both a Receiving Office and an International Searching Authority.

The PCT's scope covers utility-type inventions — processes, machines, manufactures, and compositions of matter — but does not extend to design patents. Applicants who need design protection in multiple jurisdictions must use the Hague System for industrial designs, a separate WIPO mechanism. Plant variety protection falls outside PCT coverage entirely.

The regulatory framework that governs U.S. patent rights, including how PCT applications interact with domestic prosecution requirements, is detailed in the regulatory context for patent law.

How it works

A PCT application passes through two defined phases: an international phase and a national/regional phase. The distinction between these phases is operationally critical.

International Phase

1. Filing: The applicant files a single international application with a Receiving Office — the USPTO for U.S.-resident applicants, or WIPO's International Bureau directly. The filing must occur within 12 months of the priority date established under the Paris Convention if claiming priority from an earlier national application.

2. International Search Report (ISR): An International Searching Authority (ISA) — which for U.S. applicants is typically the USPTO — searches prior art and issues an ISR along with a Written Opinion on patentability. This report is issued approximately 16 months after the earliest priority date (WIPO PCT Applicant's Guide, Chapter 7).

3. International Publication: WIPO publishes the international application 18 months after the priority date. This publication establishes prior art against later-filed applications worldwide.

4. Optional International Preliminary Examination (Chapter II): Applicants may request a supplementary examination under PCT Chapter II, receiving a nonbinding International Preliminary Report on Patentability (IPRP). This step allows applicants to argue patentability before national fees are paid and adds approximately 6 months to the international phase window.

National/Regional Phase

Entry into the national or regional phase occurs at 30 months from the priority date for most contracting states (a deadline sometimes shortened to 20 months in jurisdictions that have not adopted the extended deadline). At this point, the applicant pays individual national fees, files translations where required, and prosecution proceeds under each jurisdiction's domestic patent law. The PCT itself provides no guarantee of grant — patentability is decided independently by each national or regional office.

Key timeline benchmark: The 30-month national phase entry deadline gives applicants roughly 18 additional months beyond the standard Paris Convention 12-month priority window to evaluate commercial potential before committing to jurisdiction-specific filing costs.

Common scenarios

Startup with limited resources: A U.S.-based startup files a provisional patent application, then files a PCT application within 12 months claiming that provisional's priority date. The PCT's 30-month window allows the startup to defer per-country fees — which can exceed $10,000 to $30,000 per jurisdiction when attorney fees are included — while seeking licensing partners or investment.

Multinational corporation with broad portfolio: A corporation files PCT applications as a standard protocol for any invention with projected market relevance in Europe, East Asia, and North America. The ISR serves as a preliminary patentability signal that informs internal go/no-go decisions before national phase entry costs are committed.

Applicant seeking European regional phase: Rather than entering national phase in each individual European country separately, an applicant enters the regional phase at the European Patent Office (EPO) through a Euro-PCT application. A single EPO grant can then be validated in individual European Patent Convention (EPC) member states at a fraction of the cost of separate filings.

The patent application process page covers the domestic prosecution steps that follow national phase entry in the United States.

Decision boundaries

PCT vs. direct Paris Convention filing: If an applicant needs protection in only 1 or 2 foreign jurisdictions, direct national filings under the Paris Convention priority period may be more cost-effective than a PCT filing, which carries its own international filing fees. WIPO's fee schedule lists the basic PCT international filing fee at approximately 1,330 Swiss francs for applications up to 30 pages (fees current per WIPO Fee Tables), before ISA fees are added.

PCT vs. trade secret: For inventions in fast-moving technology sectors, the 30-month PCT timeline may allow competitors to design around a disclosed application. The trade secret vs. patent analysis is relevant for applicants weighing disclosure obligations against exclusivity benefits.

Chapter I vs. Chapter II: Most applicants do not elect Chapter II international preliminary examination because the IPRP is nonbinding and the delay adds cost. Chapter II is most useful when the Chapter I Written Opinion identified significant prior art and the applicant wants to establish a prosecution record before entering national phase.

Jurisdictions outside PCT coverage: A small number of countries with commercially relevant patent systems are not PCT contracting states or are party only to regional systems. Taiwan, for example, is not a PCT member; direct filing in the Taiwan Intellectual Property Office is required within the Paris Convention priority window.

The full patent cooperation treaty reference page provides additional procedural detail on filing requirements, fee calculations, and national phase entry procedures across major jurisdictions. Broader context on the scope of U.S. patent law is available at the site index.